Guanylate Cyclase Activators [MoA] - N0000185499
Pharmacologic Class Information
Pharmacologic Code | N0000185499 |
Pharmacologic Name | Guanylate Cyclase Activators |
Pharmacologic Uses |
|
Pharmacologic Concept | Mechanisms of Action - [MoA] |
Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with Guanylate Cyclase Activators
The table contains 4 products whose active ingredient are classified under the same pharmacologic class Guanylate Cyclase Activators [MoA].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
0456-1201 | Linzess | Non-Proprietary Name: Linaclotide | Capsule, Gelatin Coated | Oral | Allergan, Inc. | ACTIVE | |
0456-1202 | Linzess | Non-Proprietary Name: Linaclotide | Capsule, Gelatin Coated | Oral | Allergan, Inc. | ACTIVE | |
0456-1203 | Linzess | Non-Proprietary Name: Linaclotide | Capsule, Gelatin Coated | Oral | Allergan, Inc. | ACTIVE | |
65649-003 | Trulance Immediate release | Non-Proprietary Name: Plecanatide | Tablet | Oral | Salix Pharmaceuticals Inc. | ACTIVE |